ReviewLung Cancer (Auckland, N.Z.)2021

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs).

Nicholas Giustini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.